SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Collegium's OxyContin rival is first drug using Deterx anti-abuse tech launched in US

21-Jun-2016 - Collegium Pharmaceutical has launched the first product formulated using its Deterx anti-abuse technology in the US.

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

Replicating DNA structures is key to faster gene therapy vector manufacturing says Touchlight

10-Jun-2016 - Replicating secondary structures in viral DNA could be key to developing to faster AAV vector production methods according to UK tech firm Touchlight.

update

Cobra and Touchlight aim to make AAV vector production faster and cheaper

07-Jun-2016 - Cobra Biologics has teamed up with Touchlight to test an AAV vector production platform they claim will make manufacturing gene therapies for trials cheaper and faster.

US FDA approved implant offers opioid addicts six-months continuous treatment

02-Jun-2016 - The US FDA has approved Probuphine, a subdermal buprenorphine treatment for opioid dependence using Titan Pharmaceuticals’ ProNeura drug delivery platform.

EU approves second indication for subcutaneous form of Roche's rituximab

01-Jun-2016 - Roche’s subcutaneous formulation of MabThera is about reducing the treatment burden for patients and not protecting it from impending biosimilar competition, the firm says.

Novo Nordisk and Sanofi diabetes combo drugs receive US recommendation

26-May-2016 - The US FDA has voted in favour of two combination type 2 diabetes drugs putting Novo Nordisk and Sanofi head-to-head in a crowded market.

Combination therapies key to curing cancer, says Pfizer

24-May-2016 - Combination therapies and collaboration will be key in curing cancer, according to Pfizer which has seen 'astounding progress' in its immuno-oncology partnership with Merck KGaA.

Albumedix tech key to Chinese efforts to develop once-a-week diabetes drug

23-May-2016 - Recombinant albumin supplier Albumedix will help Hebei Changshan Biochem Pharma develop a once-a-week diabetes treatment.

New technique creates 'nearly pure drug' for injection

19-May-2016 - Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.

Glide begins solid dose, injectable acromegaly drug trial on birthday of most famous sufferer

19-May-2016 - A solid dose version of the acromegaly treatment octreotide developed by Glide Technologies has entered a proof-of-concept study.

Finished dosage formulations demand driving changes for CMOs

18-May-2016 - As “one of the fastest growing areas in pharma,” the demand for finished dosage formulations is having an impact on several aspects of the CMO industries.

Pfizer, Anacor enter into merger agreement

18-May-2016 - Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for approximately $5.2bn.

Biogen eyes Regenxbio delivery tech for candidate occular gene therapies

17-May-2016 - Biogen has licensed rights use a gene therapy delivery technology from developer Regenxbio.

Capsugel adds European micro-dosing capacity

16-May-2016 - Rumoured IPO-ready Capsugel has added micro-dose capabilities at its facility in Ploërmel, France citing its acquisition of Xcelience as the driver for the expansion.

Ferrer to add drug aerosol delivery tech through Alexza acquisition

11-May-2016 - Grupo Ferrer Internacional will acquire Alexza Pharmaceuticals for around $2m, adding the Staccato aerosol system to its drug delivery offerings.

New spray-dryer to handle 20kg batches, as Juniper responds to solubility demand

10-May-2016 - Juniper Pharma Services will up its solubility enhancement capabilities through the addition of a new spray-dryer at its site in Nottingham, UK.

Catalent's oral biz hit by Beinheim suspension and low modified release demand

09-May-2016 - The manufacturing suspension at a French softgel plant and low demand for modified release tech stunted Catalent’s Q3 2016 results, the firm says.

Pfizer, Wave Life Sciences partner on drug development

09-May-2016 - Wave Life Sciences is partnering with Pfizer to develop genetically targeted therapies to treat metabolic diseases.

Colorcon building film facility in Brazil to cater for growing pharma market

04-May-2016 - Colorcon is building a film coating production facility in Indaiatuba, Brazil to service markets in South America.

Biogen haemophilia spin-out to develop gene therapies and long-acting factors

04-May-2016 - The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.

French regulators lift manufacturing ban at Catalent softgel plant

02-May-2016 - Full production at Catalent’s Beinheim softgel plant has begun five months after the discovery of out-of-place capsules led to French regulators suspending operations.

Aptar launches sensor counter tech for MDIs

28-Apr-2016 - Aptar Pharma has launched a new counter technology for metered dose inhalers (MDIs) it says can help enhance patient adherence.

George Freeman: New meds and delivery methods a regulatory challenge

26-Apr-2016 -   [View the story "Live from #Biotrinity2016" on Storify]

GSK's Ware Ellipta plant to supply US after Zebulon line operational

25-Apr-2016 - GSK has confirmed its new UK plant will continue to supply the US with Ellipta inhalers after capacity at its facility in North Carolina comes online this year.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...